print-logo
Logo
  • Healthcare Consultants
  • Healthcare Managers
  • Who we are Arrow Down
    • About us
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Market Access
    • Medical Affairs
    • Government Affairs
    • Commercial Excellence
    • Patient Affairs
    • Healthcare Improvement
  • Insights Arrow Down
    • Publications
    • Project cases
    • Early Asset Strategy
    • Value Pull-through
    • Environment Transformation
  • Careers Arrow Down
    • Why join us
    • FAQ
  • Contact
  • Search Icon
  • Healthcare Consultants
  • Healthcare Managers
  • Search Icon
  • Search
Back to Our team

Craig Leighton

Consultant | London, UK

Bild von Craig Leighton

Contact

  • mail_icon c.leighton@executiveinsight.ch
  • linkedin_icon LinkedIn-Profile

Education

PhD: Neuroscience and Biophysics, University of Edinburgh
MSc: Stem Cell and Regenerative Medicine, University of Edinburgh
MRes: Neuroscience, University of Glasgow
BSc: Pharmacology, University of Strathclyde

Languages

English

A ship is always safe at the shore, but that is not what it is built for - Albert Einstein

Complete literature list


Dr. Craig Leighton, Alexandre Chappard, Dr. Rebecca S. Saleeb, Kiani Jeacock, Dr. Sarah R. Ball, Katie Morris, Owen Kantelberg, Dr. Ji-Eun Lee, Dr. Elsa Zacco, Prof. Dr. Annalisa Pastore, Prof. Dr. Margaret Sunde, Dr. David J. Clarke, Dr. Patrick Downey, Prof. Dr. Tilo Kunath, Dr. Mathew H. Horrocks
Single-Molecule Two-Color Coincidence Detection of Unlabeled alpha-Synuclein Aggregates
10th February 2023

Share this page
  • linkedin_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Contact
  • Terms of use
  • Privacy policy
  • Imprint

2025 Executive Insight. All rights reserved.